VivaCell-MTS boosts development of neonatal health care in Armenia

VivaCell-MTS boosts development of neonatal health care in Armenia

PanARMENIAN.Net - VivaCell-MTS and BirthLink have been cooperating for already 8 years now, aiming to reduce neonatal mortality and morbidity by supporting the care of sick and premature babies in Armenia. Since the start of the project, VivaCell-MTS has allocated some AMD 600 million to equip forty-three hospitals in Yerevan and the provinces.

Following the 2000 Millennium Development Goal to reduce child mortality by 2015, WHO states there is an unfinished agenda for Women and Children’s health, with newborn deaths still accounting for 44% of under-five deaths globally. Cost-effective solutions are now available to protect women and children on the day of birth: 80% of newborn deaths are caused by preventable and treatable conditions.

VivaCell-MTS will host neonatologists from maternity hospitals of the provinces and Yerevan for two days, who will be trained to achieve quality improvement, national standards of care. At the seminar, a new Neonatal Database program that enables monitoring all babies requiring intensive care after birth will be introduced.

VivaCell-MTS General Manager Ralph Yirikian, the Chief Neonatologist of Armenia Pavel Mazmanyan and the Director of BirthLink Kathy Mellor welcomed the neonatologists at the beginning of the seminar.

 Top stories
People who experienced strong social support were less likely to develop PTSD and depression, the study found.
Armenia will start acquiring confirmatory test kits to identify if a patient is positive for the novel coronavirus
The Armenian Embassy in Beijing is in touch with some 400 Armenian citizens in China, Avet Adonts said.
Tonoyan said ammunition necessary for the Armed Forces to implement their mission have grown “by tens of percent.”
Partner news